Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey

Y. Chen, W. Yao, J. Kang, B. Cai, X. Zhou, Z. Liu, P. Chen, D. Sun, J. Zheng, G. Wang, Y. Feng, Y. Xu (Beijing, Shenyang, Shanghai, Langfang, Baotou, Guangzhou, Wuhan, China)

Source: Annual Congress 2013 –COPD: acute exacerbations and others
Session: COPD: acute exacerbations and others
Session type: Poster Discussion
Number: 1870
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Chen, W. Yao, J. Kang, B. Cai, X. Zhou, Z. Liu, P. Chen, D. Sun, J. Zheng, G. Wang, Y. Feng, Y. Xu (Beijing, Shenyang, Shanghai, Langfang, Baotou, Guangzhou, Wuhan, China). Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey. Eur Respir J 2013; 42: Suppl. 57, 1870

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015



Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


COPD prevalence in Argentina: The EPOC.AR study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

2011 GOLD categories may identify different copd phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013


Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Agreement of severity stages and exacerbations building the new COPD risk groups
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013

Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014


GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015